Prism Advisors’s Amgen AMGN Stock Holding History

Prism Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,376	Closed	-$443K	–	61
2024 Q3	$443K	Hold	1,376	–	–	0.13%	52
2024 Q2	$430K	Buy	+1,376	New	+$404K	0.13%	52

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prism Advisors's AMGN Position: Q4 2024 in Review

Prism Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,376 shares — an estimated $443K sold.

Prism Advisors first reported a position in AMGN in Q2 2024 and held it in 2 quarters. The position peaked at $443K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

Prism Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
Prism Advisors sold 1,376 Amgen shares in Q4 2024, an estimated $443K.
Prism Advisors first reported a position in Amgen in Q2 2024 and held it in 2 quarters.
Prism Advisors's Amgen position peaked at $443K in Q3 2024.
2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Prism Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.